Listen to Amit G. Singal, MD, MS, and Lipika Goyal, MD, answer audience questions from a series of live CCO Webinars focused on current best practices and emerging applications with immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma.
Link to CME: Claim Credit
In this episode, Amit G. Singal, MD, MS, and Lipika Goyal, MD, answer clinician questions on current best practices and emerging applicationsĀ with immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma, with topics including:
Presenters:
Amit G. Singal, MD, MS
Chief of Hepatology
Medical Director, Liver Tumor Program
Professor, Department of Internal Medicine
UT Southwestern Medical Center
Dallas, Texas
Lipika Goyal, MD
Lead of the Liver Cancer Research Program
Assistant Professor of Medicine
Harvard Medical School
Massachusetts General Hospital Cancer Center
Boston, Massachusetts
Content based on an online CME program supported by an educational grant from Genentech, a member of the Roche Group.
Link to full program:
https://bit.ly/39V6s72